Skip to main content

Israeli company reveals nasal spray of psychedelic mushrooms

Madrigal Mental Care says the spray treats post-traumatic stress disorder, anxiety and other mental challenges. Some experts believe magic mushrooms have health benefits, though they come with risks.

Magic mushrooms sit in a fridge on July 18, 2005, in London, England.
Magic mushrooms sit in a fridge on July 18, 2005, in London, England. — Daniel Berehulak/Getty Images

Israel’s Madrigal Mental Care announced today a nasal spray featuring psychedelic mushrooms. 

The Beersheba-based biopharmaceutical company’s spray emits nanoparticles that encapsulate psilocybin, which is found in psychedelic mushrooms ("shrooms"). The spray also contains the pain drug ketamine, the recreational drug MDMA (molly or ecstasy) and other substances. The spray is designed to treat post-traumatic stress disorder (PTSD), anxiety, depression and other issues, Madrigal said in a press release. 

Related Topics

Subscribe for unlimited access

All news, events, memos, reports, and analysis, and access all 10 of our newsletters. Learn more

$14 monthly or $100 annually ($8.33/month)
OR

Continue reading this article for free

All news, events, memos, reports, and analysis, and access all 10 of our newsletters. Learn more.

By signing up, you agree to Al-Monitor’s Terms and Conditions and Privacy Policy. Already have an account? Log in